Recording Available From mRNA Vaccine Therapy Workshop
Masterclass: Nanoparticle formulation
Recordings from the recent Advances in mRNA Vaccine Therapies in Cancer Immunotherapy and Infectious Diseases Livestream
Nanotechnologies present new opportunities for advancing medical science and disease treatment in human health care.
At Precision NanoSystems, we strive to create and drive knowledge into the community through the Nanomedicine Innovation Network (NIN). On April 24, we held a livestream event on mRNA vaccine therapies at the University of Strathclyde with two of the industry leading experts. Below are the recordings from their talks.
Dr. Justin Richner earned his doctoral degree from the University of California at Berkeley. He performed his post-doctoral studies at Washington University in St. Louis studying viral immunology and vaccine development. In this setting he developed, in collaboration with Moderna, a Zika virus vaccine with the novel mRNA-lipid nanoparticle gene therapy platform. Recently, he moved to the Department of Microbiology & Immunology at University of Illinois Chicago.
Click below to view his presentation on his Zika virus vaccine research and how today he is further refining the mRNA-LNP vaccines to overcome immune-suppression and combat infectious diseases which have proven a significant challenge to traditional vaccine development.
Click here to watch video
Dr. Yvonne Perrie is an internationally recognised researcher with a strong track record of high impact publications, with approximately 100 peer reviewed manuscripts, 5 textbooks and 5 patents. Dr. Perrie has effectively delivered in various academic and motivational leadership roles including Associate Dean for Learning and Teaching, Director of the Medicines Research Unit, and Head of Pharmacy. In 2016, she moved to the University of Strathclyde as part of their Global Talent Appointment Programme. She gained her PhD from the University of London.
Click below to watch Dr. Perrie present on her multi-disciplinary research focused on the development of drug carrier systems to facilitate the delivery of drugs and vaccines, providing practical solutions for current healthcare problems.
Coming in late May through June we will have a GMP 4 part series with the industry’s top leaders in clinical development.
Want to find out how the NanoAssemblr Benchtop ® helped in advancing their research and if it would be a good solution for advancing yours?